Clinical Trial of Sacral Neuromodulation for Treatment of Refractory Overactive Bladder (OAB)

NCT02619721 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2016-10-11

No results posted yet for this study

Summary

Evaluate the long-term clinical effectiveness and safety of the PINS Sacral Neuromodulation to patients with refractory Overactive Bladder.

Conditions

  • Refractory Overactive Bladder

Interventions

DEVICE

PINS SNS

Sponsors & Collaborators

  • Beijing Hospital

    collaborator OTHER_GOV
  • Beijing Pins Medical Co., Ltd

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2017-11-30
Completion
2018-02-28

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02619721 on ClinicalTrials.gov